INNVInnovus PharmaceuticalsINNV info
$5.99info0.67%24h
Global rank8790
Market cap$812.21M
Change 7d0.00%
YTD Performance0.00%
SP500 benchmarkUnderperform
P/E-19.97
P/S1.18
Revenue$688.09M
Earnings-$43.55M
Dividend yield-
Main Sector
Healthcare

Innovus Pharmaceuticals INNV Total Debt

INNV Total Debt in 2022: $96.79M

According to Innovus Pharmaceuticals latest financial reports the total debt is $96.79M, an increase of 24.64% to 2022. At the end of 2022 company had $77.65M total debt. This figure represents the debts and financial obligations that Innovus Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.

Innovus Pharmaceuticals INNV Total Debt History from 2023 to 2022

-
Value:-

INNV Total Debt by year

YearTotal debtChange
2023$96.79M24.64%
2022$77.65M1.15%
2021$76.76M-64.22%
2020$214.52M12.23%
2019$191.15M-

View the Top Total Debt Stocks arrow right

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org